Old Web
English
Sign In
Acemap
>
authorDetail
>
Kai H. Liao
Kai H. Liao
Pfizer
Anesthesia
Drug
Medicine
Pharmacokinetics
Amyloid beta
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Risk-Based Pharmacokinetic and Drug-Drug Interaction Characterization of Antibody-Drug Conjugates in Oncology Clinical Development: An IQ Consortium Perspective.
2021
Clinical Pharmacology & Therapeutics
Chunze Li
Rajeev M. Menon
Markus Walles
Renu Singh
Vijay V. Upreti
Deanna Brackman
Anthony J. Lee
Christopher J. Endres
Seema Kumar
Donglu Zhang
Frank Barletta
Ashish Suri
Dominik Haninzl
Kai H. Liao
Bojan Lalovic
Maribel Beaumont
Peiying Zuo
Andrew P. Mayer
Dong Wei
Show All
Source
Cite
Save
Citations (0)
A Mechanistic Pharmacokinetic Model with Drug and Anti-Drug Antibody Interplay, and Its Application for Assessing the Impact of Immunogenicity Response on Bioequivalence Testing.
2020
British Journal of Clinical Pharmacology
Kai H. Liao
Chandrasekhar Udata
Donghua Yin
K. Lea Sewell
Constantino Kantaridis
Daniel Alvarez
Xu Meng
Show All
Source
Cite
Save
Citations (0)
Phase I, Masked, Placebo-Controlled, Single and Multiple Ascending Intravenous Dose Studies Evaluating Systemic and Ocular Safety, Tolerability, and Visual Acuity Effects of RN6G (PF-04382923) in Subjects with Dry, Age-Related Macular Degeneration (ARMD)
2013
Investigative Ophthalmology & Visual Science
Brian B. Berger
Pamela D. Garzone
Ivana Gunderson
Philip Fanning
Gilbert Wong
Kai H. Liao
Steven Y. Hua
John C. Lin
Show All
Source
Cite
Save
Citations (2)
1